Marianne E. Pavel

1.1k total citations · 1 hit paper
11 papers, 748 citations indexed

About

Marianne E. Pavel is a scholar working on Epidemiology, Neurology and Oncology. According to data from OpenAlex, Marianne E. Pavel has authored 11 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Neurology and 7 papers in Oncology. Recurrent topics in Marianne E. Pavel's work include Neuroendocrine Tumor Research Advances (9 papers), Neuroblastoma Research and Treatments (7 papers) and Lung Cancer Research Studies (7 papers). Marianne E. Pavel is often cited by papers focused on Neuroendocrine Tumor Research Advances (9 papers), Neuroblastoma Research and Treatments (7 papers) and Lung Cancer Research Studies (7 papers). Marianne E. Pavel collaborates with scholars based in Germany, United States and Switzerland. Marianne E. Pavel's co-authors include Lisa Bodei, James R. Howe, Dik J. Kwekkeboom, John J. Zaknun, Dieter Hörsch, M. Sue O’Dorisio, Jan Mueller‐Brand, Richard P. Baum, Marta Cremonesi and Ulrich Baum and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgical Oncology and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Marianne E. Pavel

10 papers receiving 735 citations

Hit Papers

The joint IAEA, EANM, and... 2013 2026 2017 2021 2013 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
    2013 563 citations John J. Zaknun, Lisa Bodei et al. European Journal of Nuclear Medicine and Molecular Imaging profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marianne E. Pavel Germany 5 564 470 369 256 98 11 748
Anna Sundlöv Sweden 15 439 0.8× 413 0.9× 246 0.7× 420 1.6× 131 1.3× 41 845
Jan-Paul Esser Netherlands 5 606 1.1× 485 1.0× 422 1.1× 242 0.9× 55 0.6× 6 751
Phillip G. Claringbold Australia 10 528 0.9× 536 1.1× 427 1.2× 200 0.8× 80 0.8× 12 695
Giancarlo Montini Italy 7 281 0.5× 278 0.6× 280 0.8× 160 0.6× 87 0.9× 8 537
Torjan Haslerud Germany 12 471 0.8× 445 0.9× 353 1.0× 183 0.7× 79 0.8× 24 668
Janet Lasher United States 7 220 0.4× 191 0.4× 138 0.4× 125 0.5× 31 0.3× 8 343
Karin Niepsch Germany 6 291 0.5× 359 0.8× 198 0.5× 329 1.3× 279 2.8× 13 588
Ulrike Garske Sweden 13 432 0.8× 442 0.9× 285 0.8× 296 1.2× 137 1.4× 21 902
Laura Gilardi Italy 11 195 0.3× 309 0.7× 148 0.4× 158 0.6× 86 0.9× 36 514
Beth Chasen United States 11 369 0.7× 343 0.7× 261 0.7× 122 0.5× 63 0.6× 19 557

Countries citing papers authored by Marianne E. Pavel

Since Specialization
Citations

This map shows the geographic impact of Marianne E. Pavel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marianne E. Pavel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marianne E. Pavel more than expected).

Fields of papers citing papers by Marianne E. Pavel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marianne E. Pavel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marianne E. Pavel. The network helps show where Marianne E. Pavel may publish in the future.

Co-authorship network of co-authors of Marianne E. Pavel

This figure shows the co-authorship network connecting the top 25 collaborators of Marianne E. Pavel. A scholar is included among the top collaborators of Marianne E. Pavel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marianne E. Pavel. Marianne E. Pavel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Merola, Elettra, Anja Rinke, Stefano Partelli, et al.. (2019). Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?. Annals of Surgical Oncology. 27(5). 1348–1355. 42 indexed citations
3.
4.
Rugo, Hope S., James C. Yao, Gabriel N. Hortobágyi, et al.. (2014). Meta-analysis of stomatitis incidence in everolimus (EVE) clinical studies and its relationship with efficacy.. Journal of Clinical Oncology. 32(15_suppl). 645–645. 4 indexed citations
5.
Pavel, Marianne E., Timm Denecke, Ingo G. Steffen, et al.. (2014). Streptozocin-based chemotherapy in patients with advanced pancreatic neuroendocrine tumors.. Journal of Clinical Oncology. 32(3_suppl). 295–295. 1 indexed citations
6.
Bechter, Oliver, Nicole Unger, Ivan Borbath, et al.. (2013). Open-label, phase IIIb, multicenter, expanded access study of everolimus in patients with advanced neuroendocrine tumors (NET).. Journal of Clinical Oncology. 31(15_suppl). 4138–4138. 2 indexed citations
7.
Zaknun, John J., Lisa Bodei, Jan Mueller‐Brand, et al.. (2013). The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging. 40(5). 800–816. 563 indexed citations breakdown →
8.
Fischer, Christian, Ulrich‐Frank Pape, Katharina Detjen, et al.. (2012). Prognostic relevance of circulating PIGF levels in patients with neuroendocrine tumors.. Journal of Clinical Oncology. 30(15_suppl). 4128–4128. 3 indexed citations
9.
Ahlman, Håkan, Ola Nilsson, Anne Couvelard, et al.. (2007). Poorly-Differentiated Endocrine Carcinomas of Midgut and Hindgut Origin. Neuroendocrinology. 87(1). 40–46. 62 indexed citations
10.
Pavel, Marianne E., Ulrich Baum, Eckhart G. Hahn, Detlef Schuppan, & Tobias Lohmann. (2006). Efficacy and Tolerability of Pegylated IFN-α in Patients with Neuroendocrine Gastroenteropancreatic Carcinomas. Journal of Interferon & Cytokine Research. 26(1). 8–13. 56 indexed citations
11.
Rohrer, Tilman, et al.. (2003). Pitfall of Newborn Screening for Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Neonatology. 83(1). 65–68. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Sundlöv Breakdown of academic impact, for papers by Jan-Paul Esser Breakdown of academic impact, for papers by Phillip G. Claringbold Breakdown of academic impact, for papers by Giancarlo Montini Breakdown of academic impact, for papers by Torjan Haslerud Breakdown of academic impact, for papers by Janet Lasher Breakdown of academic impact, for papers by Karin Niepsch Breakdown of academic impact, for papers by Ulrike Garske Breakdown of academic impact, for papers by Laura Gilardi Breakdown of academic impact, for papers by Beth Chasen
Rankless by CCL
2026